A systems biology approach identifies candidate drugs to reduce mortality in severely ill patients with COVID-19

Despite the availability of highly efficacious vaccines, coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lacks effective drug treatment, which results in a high rate of mortality. To address this therapeutic shortcoming, we applied a systems...

Descripción completa

Detalles Bibliográficos
Autores principales: Fava, Vinicius M., Bourgey, Mathieu, Nawarathna, Pubudu M., Orlova, Marianna, Cassart, Pauline, Vinh, Donald C., Cheng, Matthew Pellan, Bourque, Guillaume, Schurr, Erwin, Langlais, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Biomedicine and Life Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159580/
https://www.ncbi.nlm.nih.gov/pubmed/35648852
http://dx.doi.org/10.1126/sciadv.abm2510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159580/
https://www.ncbi.nlm.nih.gov/pubmed/35648852
http://dx.doi.org/10.1126/sciadv.abm2510

Ejemplares similares